SOHO 2022: Integrating Novel Agents Into the Management of Cutaneous T-cell Lymphoma

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

SOHO 2022: Integrating Novel Agents Into the Management of Cutaneous T-cell Lymphoma

By SOHO 2022 Tenth Annual Meeting FEATURING Pamela Allen

75 views

October 14, 2022

Comments 0

The First Treatment Choice Matters

Feat. A. Ip

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

FDA Approval of E7777 (Denileukin Diftitox) for R/R CTCL - Summary o…

Yale Cancer Center

F. Foss

229 views

2 weeks ago

Cutaneous Lymphoma 101: Overview on Diagnosis, Staging and Prognosis

Basem William

184 views

4 months ago

A Personalized Approach for T-Cell Lymphomas

University of Colorado Division of Hematology

B. Haverkos

209 views

1 year ago

Overview of Current and Future Management of CTCL

UChicago Medicine

N. Mehta-Shah

53 views

3 months ago

SOHO 2023 Next Questions: T-Cell Lymphoma

SOHO 2023 Eleventh Annual Meeting

M. Lunning

80 views

1 year ago

T-Cell Lymphomas: Impact of Classification on Treatment

19th Annual International Ultmann Chicago Lymphoma Symposium

N. Mehta-Shah

482 views

2 years ago

SOHO 2023: A Multidisciplinary Approach to the Management of Mycosis…

SOHO 2023 Eleventh Annual Meeting

C. Querfeld

71 views

1 year ago

Therapeutic Advances in T-Cell Lymphomas

Penn Medicine's 2023 Updates in Care of the Hematologic Malignancies Patient

S. Barta

176 views

1 year ago

Diagnosis and Evidence-Based Management of T-Cell Lymphoma

i3 Health

A. Goodman

166 views

2 years ago

2023 SOHO® Brazil: "Moving Beyond CHOP/CHOEP - How Disease Features …

SOHO Brazil 2023

A. Moskowitz

86 views

1 year ago

Advancing Therapeutic Outcomes in Aggressive B and T Cell Lymphomas

Indy Hematology Review

T. Phillips

135 views

1 year ago

Recent Updates in Lymphoma: PD-1 mAbs and Novel Cell Therapy in cHL …

University of Colorado Division of Hematology

B. Haverkos

33 views

7 months ago

IL-21 Expanded NK Cells + Mogamulizumab for Cutaneous T-Cell Lymphom…

Basem William

31 views

4 months ago

EHA and ASCO 2022 Penn Medicine Updates on Targeted Therapies and Im…

Penn Medicine Abramson Cancer Center

S. Barta

188 views

2 years ago

ASH 2022 Highlights: T-Cell Lymphoma and Hodgkin Lymphoma

Yale Cancer Center

T. Sethi

78 views

1 year ago

Lymphoma During Pregnancy

RWJBarnabas Health Rutgers Cancer Institute of New Jersey

A. Evens

160 views

2 years ago

Indy Hematology Review 2023: Expert Case Discussions

Indy Hematology Review

M. Wiemann, S. Usmani, J. Mikhael, M. Lunning, S. Treon, T. Phillips, J. Woyach

83 views

1 year ago

Venous Thromboembolism in Lymphoma: Risk Stratification, Prophylaxis…

19th Annual International Ultmann Chicago Lymphoma Symposium

K. Cohen

152 views

2 years ago

VCU Health Updates on Extranodal Lymphomas

VCU Massey Cancer Center

V. Yazbeck

57 views

2 years ago

Therapeutic Advances in T-Cell Lymphoma

Penn Medicine Abramson Cancer Center

S. Barta

42 views

2 years ago

AUTOPLAY

Login

Login

Join VuMedi

SOHO 2022: Integrating Novel Agents Into the Management of Cutaneous T-cell Lymphoma

The First Treatment Choice Matters

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Recommended

FDA Approval of E7777 (Denileukin Diftitox) for R/R CTCL - Summary o…

Cutaneous Lymphoma 101: Overview on Diagnosis, Staging and Prognosis

A Personalized Approach for T-Cell Lymphomas

Overview of Current and Future Management of CTCL

SOHO 2023 Next Questions: T-Cell Lymphoma

T-Cell Lymphomas: Impact of Classification on Treatment

SOHO 2023: A Multidisciplinary Approach to the Management of Mycosis…

Therapeutic Advances in T-Cell Lymphomas

Diagnosis and Evidence-Based Management of T-Cell Lymphoma

2023 SOHO® Brazil: "Moving Beyond CHOP/CHOEP - How Disease Features …

Advancing Therapeutic Outcomes in Aggressive B and T Cell Lymphomas

Recent Updates in Lymphoma: PD-1 mAbs and Novel Cell Therapy in cHL …

IL-21 Expanded NK Cells + Mogamulizumab for Cutaneous T-Cell Lymphom…

EHA and ASCO 2022 Penn Medicine Updates on Targeted Therapies and Im…

ASH 2022 Highlights: T-Cell Lymphoma and Hodgkin Lymphoma

Lymphoma During Pregnancy

Indy Hematology Review 2023: Expert Case Discussions

Venous Thromboembolism in Lymphoma: Risk Stratification, Prophylaxis…

VCU Health Updates on Extranodal Lymphomas

Therapeutic Advances in T-Cell Lymphoma